secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2023-11-06T23:59:59+00:00
Accession:  0001628280-23-037043
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q3 revenue down 39.6% YoY to $235.9M; EPS $2.12 vs $3.27
-----------------------------------------------------------------

- Revenue $235.9M (-39.6% YoY); net income $23.1M (-36.2% YoY); diluted EPS $2.12 vs $3.27.
- Active earning Coaches 47,100 (-28.9% YoY); revenue per Coach $5,008 (-15.1%).
- FY2023 guidance: revenue $1,050M-1,070M; diluted EPS $8.65-$9.55.
- Cash & investments $157.8M, no debt; declared $1.65/share dividend payable Nov 7.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828023037043/0001628280-23-037043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828023037043/med-20231106.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-037043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer